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Abstract
Objective: To systematically review and critically appraise all evidence on skin care advice and products
tailored for patients receiving radical radiotherapy for breast cancer and to determine an evidence-based
conclusion regarding the most effective products.
Data Resources and Review Methods: Major healthcare databases were searched with additional efforts
made to hand-search current journals. All relevant literature fulfilling the inclusion and exclusion criteria
was subjected to quality assurance checks. Those that passed underwent a more rigorous appraisal and
were included in the review.
Results: Ten studies were identified as fulfilling the review criteria with regards to aims and quality. All
were randomised controlled trials; three were double-blinded, three were single-blinded, the remaining
were not blinded. Two addressed washing regimes, two addressed deodorant use, whilst the six remaining
studies investigated creams, gels or dressings.
Conclusions: The results suggest that there is a place for creams in the management and delay of radi-
ation-induced skin toxicities; however, research fails to highlight one product which has a demonstrable
benefit over others whilst still being cost effective and free from adverse effects. Patients should not be
discouraged from washing with water or mild soaps and results suggest that the restriction of aluminium-
free deodorant during treatment is unnecessary; however, more research in this area is needed with larger
sample sizes.
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INTRODUCTION
Erythema, dry desquamation and moist
desquamation are recognised skin reactions that
can occur as a direct consequence of radio-
therapy. Despite advancements in skin sparing
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techniques, skin reactions are still the most com-
mon side effect of radiotherapy, with as many as
95% of patients experiencing some degree of
skin reaction.1,2 Erythema is defined as redness
of the skin due to dilation of dermal blood ves-
sels.3 The Acute Radiation Morbidity Scoring
Criteria, established by the Radiation Therapy
and Oncology Group (RTOG) in 1981, is still
the foremost method for assessing and reporting
radiation skin reactions (Table 1).4
Radiotherapy-induced erythema is caused by
radiation damaging the mitotic abilities of cells
within the basal layer. This weakens the integ-
rity of the skin as cells are unable to replicate
sufficiently to replace damaged tissue which
ultimately results in breakdown of the skin.
Skin reactions typically become visible after
the skin has received doses of 20 to 25 Gray
(Gy),5 usually within the second or third week
of a course of radical radiotherapy, when the
patient is receiving a maximum daily dose of 2
Gy. A peak reaction is reached approximately
1 week after treatment completion.2
The severity of skin reactions are dependent
on factors including volume of tissue treated,
total daily dose, fractionation and individual fac-
tors such as the patient’s smoking habits and
whether they are diabetic or obese.2,6 The
impact of a skin reaction on a patient’s quality
of life is often underestimated by healthcare
professionals. Moist desquamation can occur in
the infra-mammary fold following breast irradi-
ation, often having a significant impact on the
physical and psychological well-being of
patients. The reaction can be painful, unsightly
and may prevent patients from wearing a bra.
The Society and College of Radiographers
(SCoR) guidelines7 for the management of
skin reactions advises against the use of deodor-
ants and recommends that only mild soaps are
used during treatment. Such restraints can often
lead to feelings of self-consciousness associated
with body odour.5
Standard advice given to patients encourages
the daily application of ointments such as Aque-
ous cream to moisturise the skin and delay the
onset of erythema.7 During treatment patients
are encouraged to wash their skin using tepid
water and mild soap, rinsing thoroughly and
patting the area dry with a soft clean towel.
No adhesive tape or perfumed products should
be used in the treatment area peri- or post-
radiotherapy. One percent Hydrocortisone
cream can be applied sparingly to pruritic areas.8
SCoR guidelines are intended to prevent
exacerbation of the inevitable skin toxicity of
radiotherapy.1 Despite guidelines being in
place, there appears to be a wide variation in
skin care advice given to patients in radio-
therapy centres nationwide regarding the type
of creams and dressings which should be used
to manage skin reactions. There also appears
to be a variation in the washing advice given
to patients during treatment. The aim of this
study is to systematically review the evidence
on skin care products, washing regimes and
advice tailored for patients receiving radical
radiotherapy for breast cancer, and to determine
an evidence-based conclusion regarding the
most effective products to manage skin reac-
tions for these patients.
METHOD
The method used was structured around a 5-
step framework described by Khan et al.9
Framing question
This details the necessary components of
research questions. It includes a population, (a
group of participants and their clinical prob-
lem), the intervention (the main action being
considered), the outcome, clinical changes in
Table 1. A table outlining the RTOG Acute Radiation Morbidity
Scoring Criteria as described by Cox et al (1995).4
Grade Clinical presentation
1 Follicular, faint or dull erythema or dry desquamation.
Decreased sweating.
2 Tender or bright erythema or patchy moist desquamation.
Moderate oedema.
3 Confluent moist desquamation.
4 Ulceration or necrosis of skin.
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health state and the study design. This is known
as the PICO framework.10 It can be utilised for
both the research question and as a search strat-
egy for literature selection.
Identifying relevant literature
A comprehensive search was carried out using
major medical databases including CINAHL,
MEDLINE, AMED, CENTRAL (Cochrane
Central Register of Controlled Trials), DARE
(Database of Abstracts of Reviews of Effects)
and the British Nursing Index. The search per-
iod began in August 2009 and continued
throughout the writing process to ensure any
new relevant studies were included. The final
search was undertaken in September 2010. Ref-
erence lists of relevant articles were reviewed to
identify further studies. Hand searching of key
journals was carried out to help identify up-
to-date applicable articles. Key journals
included Clinical Oncology, Radiotherapy and
Oncology, European Journal of Cancer Care, Inter-
national Journal of Oncology, Biology, Physics and
the Journal of Radiotherapy in Practice. All literat-
ure searches were carried out by the two
authors. The basic search terms used are
included in Table 2.
The search method and the search terms used
were based on the results of a preliminary
search; additional search terms were included
to ensure comprehensiveness.
Only articles published in English were
included due to translation of non-English lan-
guage articles not being feasible (Figure 1).
The inclusion and exclusion criteria were
integral to the refining process. Amendments
were made during the search as the original cri-
teria was found to be too restricting and led to a
shortfall in literature within the research field of
interest excluding articles which would have
strengthened the conclusion (Table 3).
Assessing literature quality
The literature acquired was chosen using a qual-
ity checklist, ensuring the literature used was
reliable and robust enough to support the con-
clusion. Only one reviewer assessed the quality
of each article; this decision was based on finan-
cial constraints and the original format of the
Table 2. The basic search terms utilised, including truncation used
during literature searching
Components of the
literature search Key search terms
Population Breast$, Mammar$, Neoplasm$,
Tumo?r$, Cancer, Carcin$, Radiat$,
Therp$, Irradiat$ Therap$, Radiotherap$
Intervention Cream$, Ointment$, Lotion$, Gel$,
Dressing$, Topical Agent$
Outcome Erythema, Desquamation, Skin toxicity,
Skin Reaction, Acute Toxicity,
Radiation Dermatitis
Figure 1. Refining process for the literature search to aid identification of only relevant literature, it includes the number of articles
acquired (n) and excluded with each step (xn) (adapted from Khan et al. pp 229)
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article, as a university dissertation piece. The
reviewer was not blinded to the journals used
or the authors; however, no journal or author
was excluded from the search and no preferences
or prejudice shown in either area (Table 4).
Each area within the table above was
designed to address each of the known biases
that commonly occur within systematic reviews
including selection, performance, measurement
and attrition bias. Any other points of interest
found within the articles were noted to help
strengthen the review; similarly, any other areas
of weakness within the articles were noted.
Summarising evidence
The aim was to display the characteristics of the
literature chosen, grouping it into relevant cat-
egories, thus allowing trends to be seen and
the findings tabulated.
Interpreting findings
The validity of the main findings were consid-
ered. The quality of the studies and any bias
observed was analysed. Consideration was given
to how this review could be applied to clinical
practice; this being the review objective, to cla-
rify and aid the procedure within clinical prac-
tice with regard to skin care advice given to
patients with breast cancer (Table 5).
DISCUSSION
An initial literature search provided 68 research
articles; however closer analysis highlighted a
number of methodological limitations which
Table 3. The final inclusion and exclusion criteria utilised
Question component Inclusion criteria Exclusion criteria
The population * Females with clinically diagnosed breast cancer
receiving external beam photon radiotherapy to the
affected breast/s.
* Patients receiving adjuvant chemotherapy.
* Males with breast cancer
* Patients receiving electron treatment alone.
* Patients receiving cobalt treatment.
* Patients with already established moist
desquamation.
The interventions * The use of any soap and washing detergent or
comparative studies where no washing agents are used.
* The use of creams or dressings used as a skin care
method during radiotherapy.
* The use of deodorants during radiotherapy.
* Products used solely to manage moist
desquamation.
The outcome * Post-radiotherapy skin appearance.
* Peri-radiotherapy skin appearance.
The study design * Qualitative research.
* Quantitative research.
Table 4. The Quality Assessment Checklist utilised
Representation within the text
Area Adequate Inadequate Unclear/unstated
Clinical question definition
Selection criteria definition
Description of radiotherapy technique utilised
Generation of a random sequence for patient
allocation to the interventions
Allocation concealment
Blinding
Description of withdrawal
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reduced comparability and resulted in 43 articles
not being suitable for inclusion. Twenty-five
potentially useful articles were identified. Com-
mon limitations found included studies failing
to set substantive inclusion and exclusion cri-
teria, with some studies failing to report either
entirely. Methods of randomisations, blinding
and recruitment were also often reported in
insufficient depth. Many studies did not provide
reasons for non-attendance at follow-ups whilst
some of the literature appeared to lack data and
justification for chosen study methodologies.
Consequently, of the 25 articles only 10 articles
were included in the final review; the 15 that
were rejected were done so on the basis of
methodological limitations. All the studies cho-
sen fulfilled the basic requirements of the qual-
ity assessment checklist. Small but acceptable
limitations were evident in six studies. These
limitations included unclear skin assessment
methodology, justification of patient allocation
and scope for potential bias. Blinding of patients
and skin assessors was varied amongst the stud-
ies. Four studies were not blinded at
all,12,15,17,27 this was justified in three of the
studies by the interventions being investigated,
for example, it was not possible to blind patients
from their intervention when they were either
using deodorant or not or washing or not.
Three studies were single-blinded14,18,20 and
three were double-blinded11,13,16. Organoleptic
properties of some ointments and dressings
meant neither the patients nor the skin assessor
could be blinded. It was felt that some studies
could have successfully blinded their skin asses-
sors however they failed to, which could have
led to a degree of bias. These studies were still
included in the review due to their high stand-
ard of quality elsewhere, they helped strengthen
the conclusion; however, their potential for bias
was fully acknowledged. It is recommended
that future research should pay careful attention
to their blinding techniques to ensure their
results are more reliable.
A number of alternative skin assessment scales
have been developed in an attempt to compens-
ate for the simplicity of the RTOG scale.5 Five
of the studies reviewed used the RTOG scale to
assess skin12,14,17,18,20 with two of these adapt-
ing the original scale to overcome simplicity
and provide more detailed assessment12,17.
Both provided detailed descriptions of the
changes made. Five studies did not utilise the
RTOG scale,11,13,15,17,27 instead they used
alternative tools including skin assessments
scales unique to their nation, reflectance spec-
trophotometry and measurements of transepi-
dermal water loss. These four studies all
identified the scale system and provided details
with varying rigour.
Acknowledgment is given to the five studies
which used quality of life assessment question-
naires. These give insight into how skin reac-
tions and skin management techniques affect a
patient’s quality of life. The intention of these
studies and this review was to discover a best
care technique for managing radiation-induced
skin reactions thus improving a patient’s quality
of life; it seems justifiable therefore to ask
patients their opinions of these techniques. If
patients are unable to tolerate the skin manage-
ment technique despite improvement in skin
reactions, the level of compliance would be
poor thus failing to benefit the patient and pos-
sibly making promotion of this technique in a
department futile.
One of the studies investigated skin reactions
in multiple treatment areas including the breast.
Its inclusion within this review was based on
the quality of the study. It clearly outlined the
number of patients with breast cancer included
within the study and outlined their radiotherapy
treatment. Further, their results were differen-
tiated from the others. This particular study ful-
filled all the desired quality assurance criteria. It
was felt that it was inappropriate to reject a
well-written piece of literature on the basis
that it also included other radiotherapy treat-
ments aimed at treating other forms of cancer
besides breast cancer.
The SCoR guidelines recommend the use of
Aqueous cream during treatment to moisturise
the skin and delay the onset of erythema.7
However, alternative research carried out sug-
gests Aqueous cream can be counterproductive
for numerous patients. Cork et al.19 found that
56% of episodes of exposure to Aqueous cream
were associated with an immediate cutaneous
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reaction in children using the cream for man-
agement of atopic eczema. Interestingly, they
noted patients reporting reactions to Aqueous
cream obtained in one part of the United King-
dom and not another. One explanation might
be that Aqueous cream is provided by a number
of manufacturers who are permitted to use dif-
ferent preservatives. Aqueous cream was origin-
ally a wash product rather than a ‘‘leave on’’
emollient. Ingredients such as antiseptics and
surfactants are important and safe constituents
of wash products because of their transient con-
tact with the skin.19 This review encountered
one incidence of an adverse reaction to Aque-
ous cream, whilst reactions were also seen
with other products. The studies reviewed
reported 7 incidences of adverse reactions to
emollients prescribed and 3 incidences of
adverse reactions to corticosteroid creams.
Where departments follow SCoR guidelines
and use Aqueous cream, it should be recom-
mended that practitioners be made aware of
the risks of adverse reactions and how to identi-
fy them. Future research could focus on the
preservatives contained in Aqueous cream
nationally to determine how much variation
there is and how this impacts on skin care and
skin reactions.
Both studies investigating washing regimes
concluded that washing was beneficial to
patients and should not be discouraged; there
was no reported difference between washing
with or without mild soap in terms of acute
skin toxicity. Washing with soap appeared to
provide psychological relief to many patients.
This supported the recommendation by the
SCoR that patients should be allowed to use
mild soaps throughout treatment. The literature
search highlighted a lack of studies within this
area of skin care.
Another area of skin care found to cause psy-
chological distress is the restricted use of
deodorant.20 This area of skin care is also un-
der-researched and would benefit from further
investigation. At present a literature search
identified only five studies focussing on this
area of skin care.2022,26,27 Only two were uti-
lised in this review.20,27 One study was rejected
because the study design was a laboratory-based
study, this could not have been compared to
any other study and it did not place enough
emphasis on patient judgement. The other
rejected study had a number of methodological
flaws including insufficient data regarding radio-
therapy techniques used, a lack of statistical sup-
port and detail of inclusion criteria. The final
study was a literature review and survey. The
survey, which provided important feedback
from patients, however, was not comparative
to any other study. The literature review
reported the same number of articles in this
area as was found with this review. All five
studies advocate the use of deodorant safely
throughout radiotherapy treatment despite
most radiotherapy departments advising patients
against it.
Four studies investigated the use of creams or
gels containing anti-inflammatory properties
compared with emollient creams. They indi-
cated a slight benefit in terms of acute skin tox-
icity within the anti-inflammatory groups.
Products containing anti-inflammatory proper-
ties included Calendula officinalis, Aloe vera and
corticosteroid creams such as Mometasone Fur-
ote and Methylprednisolone Aceponate.
The use of corticosteroid creams is not routi-
nely recommended due to the side effects asso-
ciated with their use. They can cause thinning
of the skin, increasing the risk of moist
desquamation and the introduction and spread
of bacterial infections. Patients should be
advised on how to correctly apply the cream
and be monitored, assessing for signs of bacterial
infection.23
Five studies investigated the use of emollient
creams. Upon analysis, all emollients appeared
to have similar results with no considerable dif-
ference between products. This conclusion cor-
relates with similar reviews carried in the last
decade.2,24,25
The choice of skin care products used within
departments is influenced by many factors. One
study highlighted the significance of cost.
According to the British National Formulary
(BNF)23 100 g of Aqueous cream costs £1.36
whilst corticosteroid creams are as expensive
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as £12.82 for 100 g. There is also a noticeable
difference in price between emollients. Other
factors motivating departmental choice include
organoleptic qualities of the products. Three
studies identified patient preference influenced
by the smell, texture and colour of creams
or gels.
CONCLUSION
Of the 10 skin care ointments investigated
within the 10 research articles, no one product
appeared to have an overall benefit over others.
Although patients using corticosteroid creams
had a slight increased benefit in terms of eryth-
ema, its use is not routinely encouraged due to
side effects.
Evidence suggests that patients should not be
discouraged from washing and mild soaps
should be permitted. Similarly, the use of non-
metallic deodorants does not seem to have a
detrimental effect on patient’s skin reactions;
also, patient feedback suggests that the restric-
tion of deodorant use can psychologically
harm some patients.
Future research could be strengthened by
developing universal methods of skin assessment
and ensuring that wherever possible participants
and assessors are blinded to the interventions
being used.
Radiotherapy departments should be encour-
aged to follow evidence-based guidelines with
regard to support and management of skin reac-
tions rather than provide advice based on tradi-
tion and cost.
Recommendations for future areas of
research include variations in Aqueous cream
ingredients and more extensive research into
the use of deodorants throughout radiotherapy
for breast cancer.
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